-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
SJZ No.4 Pharmaceutical
SSY Group Limited (Shijiazhuang No.4 Pharmaceutical Co., Ltd.) is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products and medical packaging materials. It ranks among the top 100 enterprises in China's pharmaceutical industry and the excellent export-oriented enterprises in chemical and pharmaceuticalpreparation industry. In 2007, the company was listed on the main board of Hong Kong (SSY Group Limited, 02005.HK).
For more than 70 years, the Group has braved the wind and rain and forged ahead. Especially in the past 20 years, under the leadership of Mr. QuJiguang, the Group has changed from a small workshop to a large listed company, and the enterprise has achieved a fundamental change and qualitative leap.
At present, the Group has 9 subsidiaries with more than 4,800 employees, assets of 7.4 billion RMB and main business income of more than 5 billion RMB. It has a multi-category business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological pharmaceutical products and medical packaging materials. The Group has formed an entire industrial chain of R&D, production and application of characteristic APIs, new preparations, and medical packaging materials. The annual production capacity of injection products can reach 3 billion bottles/bags, and the production scale and technical level are among the best in China.
The flexible operation mode and differentiated marketing and service make the Group's brand products win the praise of consumers. The products radiate all over the country and are exported to more than 90 countries and regions overseas.。
Group Strength
For more than 70 years, the Group has braved the wind and rain and forged ahead. Especially in the past 20 years, under the leadership of Mr. QuJiguang, the Group has changed from a small workshop to a large listed company, and the enterprise has achieved a fundamental change and qualitative leap.
-
76
76 years of experience in pharmaceutical production and R&D
year -
10
The group has 10 subsidiaries.
home -
60
Main business revenue reached RMB 6 billion.
hundred million -
6500
The group has more than 6,500 employees.
person -
100
Group assets exceed RMB 10 billion.
hundred million -
40
Annual production capacity of injectables: 4 billion (vials/bottles/bags)
hundred million -
100
Exported to more than 100 countries and regions across Asia, Europe, Africa, the Americas, and Oceania.
one -
32
The product is distributed across 32 provinces, municipalities directly under the central government, and autonomous regions nationwide.
one
The Subsidiaries
Hebei Guangxiang Technology Co., Ltd.
Hebei Guolong Pharmaceutical Co., Ltd.
Jiangsu Best New Medical Material Co., Ltd.
Company Honors
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
